M&A trends to watch out in pharma
Express Pharma
JUNE 12, 2024
With additional firepower, the pharma companies are looking to acquire innovative technologies specifically in precision medicine, cell and gene therapy, cancer and rare diseases, diabetes, auto-immune diseases, and weight loss which will hurl additional M&A activity.
Let's personalize your content